NCT00947440View on ClinicalTrials.gov

Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2009

Conditions
Hepatitis C
Interventions
DRUG

ABT-072

See arm description for more information

Trial Locations (1)

60085

Site Reference ID/Investigator# 22384, Waukegan

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY